The paradox of race in the Bidil debate.
Crawley
LaVera
L
D001741:Black or African American / Q000235:genetics* / Q000523:psychology; D017277:Drug Approval; D004338:Drug Combinations; D006333:Heart Failure / Q000188:drug therapy* / Q000208:ethnology*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D044469:Racial Groups / Q000145:classification*; D012933:Social Identification; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; C431665:isosorbide-hydralazine combination; D006830:Hydralazine; D007548:Isosorbide Dinitrate